# Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension

Study · id `cardio:ct-nct04790279` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04790279](<https://clinicaltrials.gov/study/NCT04790279>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04790279

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.

## Technical summary

Registry record NCT04790279. Randomized; no masking; primary purpose treatment. Start 2021-04-09 (actual); primary completion 2022-12-13 (actual). Results posted on 2024-10-28.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 175 participants (enrolled count; ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Started: 2021-04-09 (actual) (ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Primary completion: 2022-12-13 (actual) (ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Completion: 2023-01-25 (actual) (ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Results first posted: 2024-10-28 (ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04790279, source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04790279-2024-10-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
- Condition: Hypertension in Pregnancy
- Intervention (Drug): Amlodipine
- Intervention (Drug): NIFEdipine ER
- Lead sponsor: Prisma Health-Upstate
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry intervention is a member of this class by a sourced record link: Calcium channel blockers (`cardio:calcium-channel-blockers`)
- Registry lists this organization as the lead sponsor: Prisma Health-Upstate (`cardio:org-prisma-health-upstate`)

## Provenance

Content hash: 979780149ee58f69c29ef5c974940654de2551763eac76b0dd6abe96ec50e9e5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
